Candida auris is a dangerous fungal pathogen that has become a global health concern. It spreads easily in health care settings and can cause life-threatening infections, especially in patients with ...

However, scientists have now become increasingly aware that antifungal pesticides and antifungal drugs share some of the same mechanisms. The authors therefore warned that the promulgation of ...

Psoriasis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

Engineers at Brown University have designed a nanoscale drug delivery system that enhances the effectiveness of an antifungal drug against Candida species, including drug-resistant strains such as ...

Enter a new antifungal, mandimycin. It’s the latest addition to a group of antifungals called glycosylated polyene macrolides, but it works differently from the rest. That could help it evade ...

Understanding a drug’s mechanism of action (MOA) can greatly increase the likelihood of successful clinical trials by identifying biomarkers of patient response and providing a rationale for ...

EP: 6. Future Perspective on Anemia Treatment in LR-MDS Video content above is prompted by the following: Please discuss how the mechanism of action differs between luspatercept and epoetin alfa and ...

U.K.-based biotechnology company F2G has raised $100 million to complete late-stage testing of a new kind of antifungal treatment and bring it back to U.S. regulators’ desks after they rejected it ...

Replacing old pesticides with new pesticide varieties has been the main means to solve pesticide resistance. Therefore, it is necessary to research and develop new antifungal agents for plant ...

After F2G’s first attempt to get a brand-new class of antifungal to market was derailed by the FDA, the U.K.-based biotech has secured $100 million in fresh funding to bankroll another push ...